Nalaganje...
The efficacy and safety of co-administration of fimasartan and rosuvastatin to patients with hypertension and dyslipidemia
BACKGROUND: Hypertension and dyslipidemia are major risk factors of cardiovascular disease (CVD) events. The objective of this study was to evaluate the efficacy and safety of the co-administration of fimasartan and rosuvastatin in patients with hypertension and hypercholesterolemia. METHODS: We con...
Shranjeno v:
| izdano v: | BMC Pharmacol Toxicol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217661/ https://ncbi.nlm.nih.gov/pubmed/28057081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-016-0112-7 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|